Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Verweij

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Genes and Immunity|September 23, 2011
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosisJ T Tossberg, P S Crooke, M A Henderson, et al.
Blood|February 1, 1990
Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individualI R Peake, M B Liddell, P Moodie, et al.
Rheumatology (Oxford, England)|November 21, 2000
Are differences in interleukin 10 production associated with joint damage?T W Huizinga, V Keijsers, G Yanni, et al.
Arthritis and Rheumatism|March 17, 2004
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort studyF A van Gaalen, S P Linn-Rasker, W J van Venrooij, et al.
Clinical and Experimental Immunology|January 1, 1994
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gammaM E van den Dobbelsteen, V Verhasselt, J G Kaashoek, et al.
Clinical Immunology and Immunopathology|October 1, 1994
Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritisJ A Kummer, P P Tak, B M Brinkman, et al.
Annals of the Rheumatic Diseases|February 14, 2004
Activation of the STAT1 pathway in rheumatoid arthritisP V Kasperkovitz, N L Verbeet, T J Smeets, et al.
Genes and Immunity|June 18, 2010
Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritisL G M van Baarsen, C A Wijbrandts, D M Gerlag, et al.
Annals of Neurology|June 9, 1999
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosisA H van Boxel-Dezaire, S C Hoff, B W van Oosten, et al.
Genes and Immunity|February 24, 2001
Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritisM V van Krugten, T W Huizinga, E L Kaijzel, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Genes and Immunity|September 23, 2011
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosisJ T Tossberg, P S Crooke, M A Henderson, et al.
Blood|February 1, 1990
Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individualI R Peake, M B Liddell, P Moodie, et al.
Rheumatology (Oxford, England)|November 21, 2000
Are differences in interleukin 10 production associated with joint damage?T W Huizinga, V Keijsers, G Yanni, et al.
Arthritis and Rheumatism|March 17, 2004
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort studyF A van Gaalen, S P Linn-Rasker, W J van Venrooij, et al.
Clinical and Experimental Immunology|January 1, 1994
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gammaM E van den Dobbelsteen, V Verhasselt, J G Kaashoek, et al.
Clinical Immunology and Immunopathology|October 1, 1994
Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritisJ A Kummer, P P Tak, B M Brinkman, et al.
Annals of the Rheumatic Diseases|February 14, 2004
Activation of the STAT1 pathway in rheumatoid arthritisP V Kasperkovitz, N L Verbeet, T J Smeets, et al.
Genes and Immunity|June 18, 2010
Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritisL G M van Baarsen, C A Wijbrandts, D M Gerlag, et al.
Annals of Neurology|June 9, 1999
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosisA H van Boxel-Dezaire, S C Hoff, B W van Oosten, et al.
Genes and Immunity|February 24, 2001
Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritisM V van Krugten, T W Huizinga, E L Kaijzel, et al.
Pageof 10